Jeffrey W. Corbett - Concepedia

Author

Jeffrey W. Corbett

Wilmington University

Also Known As

J. W. CORBETT, J. W. Corbett, J.W. Corbett, Jeffrey Corbett, Jeffrey W Corbett, Jeffrey W. Corbett, M.D. Anderson

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Wilmington University DuPont (United States)Experimental Station Pfizer (United States)The University of Texas at Austin

About

Jeffrey W. Corbett is an author at Wilmington University specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	483
2	Natural Sciences	7	7	394
3	Biochemistry	4	4	233
4	Chemical Biology	4	4	207
5	Chemistry	4	4	213

Jeffrey W. Corbett

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors Jeffrey W. Corbett, Soo S. Ko, James D. Rodgers, Journal of Medicinal Chemistry	2000	299
Expanded-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors Inhibit Clinically Relevant Mutant Variants of Human Immunodeficiency Virus Type 1 Jeffrey W. Corbett, Soo S. Ko, James D. Rodgers, Antimicrobial Agents and Chemotherapy Dpc 963MedicineHuman RetrovirusImmunologyPharmacology	1999	119
Solid-Phase Synthesis of Benzopiperazinones Guillermo A. Morales, Jeffrey W. Corbett, William F. DeGrado The Journal of Organic Chemistry	1998	88
Facile Preparation of 2,6-Disubstituted Purines Using Solid-Phase Chemistry David A. Nugiel, Lyndon A. M. Cornelius, Jeffrey W. Corbett The Journal of Organic Chemistry Medicinal ChemistryPharmaceutical ScienceNatural SciencesMedicine2,6-Disubstituted Purines	1997	78
Solid-phase synthesis of a selective αvβ3 integrin antagonist library Jeffrey W. Corbett, Nilsa Graciani, Shaker A. Mousa, Bioorganic & Medicinal Chemistry Letters Peptide EngineeringPeptide SciencePeptide TherapeuticsChemical BiologyMolecular Pharmacology	1997	69
Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus Jeffrey A. Pfefferkorn, Angel Guzmán-Pérez, Peter J. Oates, MedChemComm	2011	68
Applications of Vinylogous Mannich Reactions. Asymmetric Synthesis of the Heteroyohimboid Alkaloids (-)-Ajmalicine, (+)-19-epi-Ajmalicine, and (-)-Tetrahydroalstonine Stephen F. Martin, Cameron W. Clark, Jeffrey W. Corbett The Journal of Organic Chemistry Medicinal ChemistryVinylogous Mannich ReactionsBioorganic ChemistryNatural SciencesAsymmetric Synthesis	1995	61
Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2 Jeffrey W. Corbett, Kevin D. Freeman‐Cook, Richard L. Elliott, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryNatural SciencesMedicineDrug Development	2009	58
Maximizing Lipophilic Efficiency: The Use of Free-Wilson Analysis in the Design of Inhibitors of Acetyl-CoA Carboxylase Kevin D. Freeman‐Cook, Paul A. Amor, Scott J. Bader, Journal of Medicinal Chemistry Pharmaceutical SciencePharmacotherapyChemical BiologyEnzymatic ModificationPharmaceutical Chemistry	2011	54
The Stereochemical Course of Nucleophilic Additions of 2-Trialkylsiloxyfurans to Cyclic<i>N</i>-Acyliminium Ions Stephen F. Martin, Jeffrey W. Corbett Synthesis HeterocyclicBiochemistryCyclic N-acyliminium IonNatural SciencesOrganic Chemistry	1992	52

Page 1